//Your Connection to the Life Sciences Industry
Connect to IBC:LinkedIn iconTwitter iconFacebook iconBlog iconRSS icon

Find Another IBC Event

AsiaTIDES: Oligonucleotide and Peptide Research, Technology and Product Development


Where Global Oligonucleotide and Peptide Leaders Connect to Share Groundbreaking Science and Form Successful Business Collaborations

March 03 - March 05,--> 2015 · Osaka, Japan



Updated: February 4, 2015

Gold Sponsor
Nitto Avecia

Driven by Excellence, Guided by Experience. When you partner with Avecia, (www.Avecia.com) you will be working with the leading oligonucleotide CMO. Avecia offers the most extensive process validation experience in the oligo industry. As a member of the Nitto Denko Corporation (www.nitto.com), Avecia is committed to the future of the oligonucleotide market. We offer our customers oligo manufacturing capacity in two separate facilities (MA and OH). Our Cincinnati facility also provides expanded pre-clinical oligo services (OliGROW), as well as small molecule expertise and production. Our aim is to leverage our wealth of experience, to ensure we exceed our customer's expectations. Avecia has the stability and vision required for the long-term success of your oligo program.

Silver Sponsors
Agilent Technologies

Agilent's Nucleic Acid Solutions Division offers industry leading experience to efficiently advance your lead oligo candidates from clinic to market with a common goal of patient health and safety. With Agilent, you always have peace of mind by partnering with a company that has the financial resources, stability and vision required for long-term success. Contact us at: pdl-boulderinfo@agilent.com and find out why the world's most revolutionary biotech companies and their Big Pharma partners are choosing Agilent Technologies to develop and commercialize their oligo APIs.

ChemGenes Corporation

Established in 1981, ChemGenes, an ISO9001 certified company, has consistently provided the highest quality Phosphoramidites and Solid Supports in the market and continues to lead the industry in oligonucleotide reagent manufacturing. Our Massachusetts facility is setup for Bulk Therapeutic Grade phosphoramidite production for GMP grade oligonucleotide manufacturing. Additionally, ChemGenes carries the widest variety of modified phosphoramidites and supports currently used in oligonucleotide synthesis including Microarray Technology, Oligonucleotide Therapeutics, Oligonucleotide Based Probes and other areas of Nucleic Acid research. ChemGenes remains devoted to providing you with invaluable customer service and comprehensive technical support.


Lonza offers the life sciences market a full range of bioresearch products, development services and manufacturing for active ingredients. For 30 years we have been helping companies increase product quality, improve production processes, navigate regulatory hurdles, lower costs, and get to market faster. From early development to in-market supply, our complete development services, industry-leading manufacturing processes, broad technology platform and lifecycle management experience can help take your product to the next level. For flexible, high-quality manufacturing, development services and products, we can help.

Bronze Sponsors

Bachem specializes in the manufacture of peptides and complex small molecules as APIs as well as innovative biochemicals for research purposes. We offer technical consultancy, comprehensive regulatory affairs support, and dedicated project management from drug development through commercial scale cGMP production. Headquartered in Bubendorf, Switzerland with affiliates in Europe and the U.S.

Gene Design, Inc

GeneDesign offers contract manufacturing of various therapeutics and diagnostics oligonucleotide including PEGylation, peptide conjugation and ligand conjugation from screening use to hundreds gram GMP manufacturing with sterilized condition. With our widely experience and challenge to the new technology area, we can contribute to your successful oligo therapeutics development. We have launched new miRNA Inhibitor called "S-TuD" and miRNA mimic as a research tools and started novel liquid phase oligonucleotide synthesis.

BioSpring GmbH

For more than 16 years, BioSpring has been providing manufacturing and analytical services for the oligonucleotide market. We manufacture an entire range of unmodified and modified oligonucleotides from mg to multi-kg quantities for the use in therapeutic (GMP) and diagnostic applications (ISO 13485 certified), molecular biology, and research and development. In addition, we have a dedicated analytical team and employ state of the art techniques for fully testing and characterizing oligonucleotides and oligonucleotide containing products. For additional information, contact us via email: info@biospring.de.

Session Sponsors
Agilent Technologies Nitto Avecia
Spotlight Presentation Sponsors
Agilent Technologies Ajinomoto Co, Inc Nitto Avecia
Bachem BioSpring GmbH
Networking Reception Co-Sponsors
ChemGenes Corporation Lonza
Literature Sponsor
Peptide Machines
Refreshment Break Sponsors
Thermo Fisher Scientific TriLink BioTechnologies